Vestaron raised more funding for biopesticide development

Date:05-15-2012


Vestaron Corporation is pleased to announce that it has completed a Series B Preferred Stock financing, totaling approximately $10.2 million, with participation by major new investors and existing investors.

Proceeds from the Series B financing are being used for continued commercial development of Vestaron's biopesticide peptide based product, accelerated research for synthetic mimics to these peptides, and expanded agricultural biotechnology research and development of the use of Vestaron's peptide as a Bt replacement in GMO portfolios.